Clinicopathological Features, Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase (ALK) Rearrangement-Based Survival of Patients With Advanced Non-small Cell Lung Cancer in a Tertiary Care Setting.

Cureus · 2024 · PMC11753902 · PMID 39850198

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

did not reach statistical significancep = 0.084so close (0.05 < p ≤ 0.1)

The study analyzed the impact of EGFR and ALK mutations on patient outcomes, revealing that although the p-values did not reach statistical significance (p = 0.084 for EGFR and p = 0.255 for ALK), the observed values and cumulative survival probabilities suggest the potential influence of these genetic alterations on NSCLC prognosis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.